Midway this morning has released itโs Japanese and Chinese price negotiations, with increases of ~8% for FY22 on increasing volumes.
This is a 'return to normal' but not 'peak cycle' prices - to be honest, was hoping for a bit more, but the big shift still expected in FY22+
To put a bit of perspective around it, we're returning in 2021-22 back to the good ol' days of 2018-19 prior to the Covid crisis that gutted volume and prices.
Export prices essentially have two impacts. First is the direct impact on revenue and earnings.
Somewhere around ~30% will be consumed by increased contractor prices, resulting in around 70% hitting the bottom line. That is $20m rev's and $14m NPAT, akin to FY18&19 margins.
Way back when, Midway was paying dividends of 18c per share in FY18 / FY19 at export prices of ~US$180 with lower volumes.
Share price was also significantly higher, and there has been no dilution since.
The second impact of export prices is on biological asset values, representing ~70% of NAV.
We have not received an update on future export prices used in calculating their assets (orange line), though it will be higher than FY20.
Because of increasing ownership of plantations (less reliance on contracted suppliers), the sensitivity to 10% price change has increased from $2.5m in FY18 to $12m in FY21.
So an +8% export price should be around $10m NAV (I previously estimated $9m).
I still believe that the current EV of $125m is a ~10% discount to the NAV, and with increasing agricultural land values and increasing export prices, we *should* see NAV increasing and the discount decreasing ๐ค
Though this is an unloved illiquid micro cap, so... ๐คท
If you enjoyed this, bash the like / retweet / follow buttons.
A deep dive per week is my commitment to FinTwit.
Questions and feedback always welcome. DYOR.
Disclaimer, I'm long MWY.
Super illiquid stock - so this sort of stuff happens on the slightest good news (like it did last year on bad news in reverse)
But there's simply no volume or depth. Currently, around 8x buyers vs sellers.
I know I know, don't get excited on daily movements.. BUT this is fundamentally the earnings forecast for next 12 months. So, something to get excited about ๐
โข โข โข
Missing some Tweet in this thread? You can try to
force a refresh
The global salmon industry is in turmoil as fears of contagion of the Norwegian resource tax hits the Faroe Islands.๐
P/F Bakkafrost $BAKKA is down another 12% overnight, while the big Norwegians $MOWI $SALM $LSG continue to slide.
Let's take a look at the Faroe Islands ๐งต๐
1. Yesterday I looked at Norway's resource tax and figured it was too difficult to find a good risk/reward bet. Right now the best forecasters of European monetary and fiscal policy seem to be a random number generator. Today I'm looking at Faroe Islands.
Norway produces over 50% of the world's Atlantic salmon. So this is kind of a big deal.
Unsurprisingly, the largest salmon companies in the world are also in Norway. In fact, the four largest are from Norway. This is because they have a huge cost advantage in the cold fjords which provide better growing conditions.
Delorean's $DEL $DEL.AX update to the market has left a fair bit to be desired. Engineering division has been decimated, financing remains out of reach, though retail is doing alright. Time to hit the panic button? ๐จ
Let's take a closer look ๐ค๐งต๐
If you don't know what Delorean is, please don't @ me, just look at the original deep dive.
Clean Seas $CSS $CSS.AX FY22 results look really good. I recently spoke with Rob Gratton (CEO) and got to understand more of their business model and strategic direction.
Here's a short thread on my thoughts and why I don't hold ๐ค๐งต๐
The FY22 results look very strong. Volume growth (3.7kt), ~20% increase in pricing, ~37% revenue increase, 19% reduction in production costs, etc. And for the first time, profitable! ๐ฏ
But I have mentioned before, this is really a bull-whip effect from the diabolical FY20 which saw inventory build up etc, and now being sold in FY22.
Treasury Wine Estates $TWE $TWE.AX FY22 results came out, and they're good considering the China wine-ban is still being flushed out. Total revenues down, but margins and NPAT are both up ๐ท๐
Let's take a quick look ๐
You can find my original thread here where I outlined TWE as an asset play, with the hope that profits may return in due course.
To put in perspective the FY22 results, you can see here the 1H22 results were less negative than the market expected. But 2H22 has been pretty strong, which is why NPAT is up *only* 4% but almost 10% if you annualise 2H22.